šŸ’° Financial Performance

Revenue Growth by Segment

In Q2 FY26, Vegetable Oil revenue grew by 41% YoY, while Animal Feed revenue remained flat despite 18% volume growth in cattle feed. Stand-alone Crop Protection revenue declined sharply by 30% YoY. Consolidated revenue for H1 FY26 reached INR 5,182 Cr, an 8% YoY increase.

Geographic Revenue Split

Not disclosed in available documents; however, the company faces competition from both domestic and external players in the agro-chemicals segment.

Profitability Margins

Consolidated Net Profit Margin improved to 4.3% in FY25 from 3.8% in FY24. Operating Profit Margin rose to 8.7% in FY25 from 7.3% in FY24. In Q2 FY26, Vegetable Oil margins expanded to 22.4% due to higher realizations and extraction ratios.

EBITDA Margin

Operating margins were 9.0% in FY25 compared to 7.6% in FY24. Astec LifeSciences reported gross margins of 44% in Q2 FY26, a 4-5 year high, and is working toward breaking even on EBITDA.

Capital Expenditure

The company has a planned capital expenditure outlay of approximately INR 250-270 Cr per annum over the near term to support growth and recent acquisitions.

Credit Rating & Borrowing

CRISIL reaffirmed a 'Crisil A1+' rating for the INR 1,500 Cr Commercial Paper programme. The company maintains strong financial flexibility as part of the Godrej Group, allowing it to raise debt at competitive rates.

āš™ļø Operational Drivers

Raw Materials

Key raw materials include Fresh Fruit Bunches (FFB) for palm oil, and commodities for animal feed such as maize and soya. Crude Palm Oil (CPO) and Palm Kernel Oil (PKO) realizations are critical for the vegetable oil segment.

Capacity Expansion

Not disclosed in available documents; however, the company is investing in value-added businesses and has recently acquired the balance stakes in Creamline Dairy Products Limited and Godrej Foods Limited.

Raw Material Costs

Raw material costs are subject to high volatility; softening commodity prices in Q2 FY26 led to lower realizations in the animal feed segment despite volume growth. Vegetable oil margins benefited from higher oil extraction ratios.

Manufacturing Efficiency

Vegetable oil efficiency is measured by the oil extraction ratio, which improved in Q2 FY26. Astec LifeSciences is driving margins through process efficiencies and cost controls.

šŸ“ˆ Strategic Growth

Expected Growth Rate

14%

Growth Strategy

Growth is driven by diversification into high-margin segments like Vegetable Oil (41% growth) and CDMO (30-31% margins). The company is focusing on process efficiencies, cost initiatives, and investing in value-added businesses while maintaining a healthy bottom-line growth trajectory of 14% YTD in H1 FY26.

Products & Services

Cattle feed, poultry feed, aqua feed, Crude Palm Oil (CPO), Palm Kernel Oil (PKO), agrochemicals (enterprise and CDMO), dairy products, and processed poultry.

Brand Portfolio

Godrej, Astec LifeSciences, Creamline Dairy Products, Godrej Foods.

New Products/Services

Not disclosed in available documents; however, the company is focusing on expanding its CDMO segment and value-added dairy/poultry products.

Market Expansion

Expansion is targeted through the palm oil business and increasing the application opportunities for agrochemicals in the crop protection segment.

Strategic Alliances

Recent acquisition of balance stakes in subsidiaries Creamline Dairy Products Limited (CDPL) and Godrej Foods Limited (GFL).

šŸŒ External Factors

Industry Trends

The industry is shifting toward diversified agri-businesses. Godrej Agrovet is positioning itself by reducing concentration in animal feed (now 48% of revenue) and growing its presence in specialized segments like CDMO and palm oil.

Competitive Landscape

Intense competition exists in the agro-chemicals business from both domestic and international players.

Competitive Moat

The 'Godrej' brand provides a significant moat, offering strong financial flexibility and favorable access to capital markets. Diversification across multiple agri-segments acts as a durable advantage against cyclicality.

Macro Economic Sensitivity

The business is sensitive to global and domestic demand-supply conditions and government regulations affecting selling prices and input availability.

Geopolitical Risks

Exposure to external players in the agro-chemicals business and global commodity price fluctuations.

āš–ļø Regulatory & Governance

Industry Regulations

Operations are subject to government regulations regarding agriculture, pollution norms, and import/export restrictions.

Taxation Policy Impact

The company's operations are influenced by changes in government regulations and tax laws.

Legal Contingencies

The company notes that important factors influencing operations include potential litigations, though specific case values are not disclosed in the provided text.

āš ļø Risk Analysis

Key Uncertainties

Climatic risks such as extreme heat impacting palm oil yields and volatility in raw material prices which can impact margins by over 100 bps.

Third Party Dependencies

The company utilizes services of third parties for operations, posing a dependency risk.

Credit & Counterparty Risk

Receivables quality is reflected in a Debtors Turnover Ratio of 17.2; liquidity is strong with over INR 400 Cr in expected internal accruals.